• 1
    Baker, N., Sandborg, C., Morris, U., and Ookhtens, M.: Competition for host essential and non-essential fatty acids by Ehrlich ascites carcinoma in mice. Cancer. Res. 37: 22182225, 1977.
  • 2
    Beaumont, V., Bérard, M., Boisnier, C., and Beaumont, J. L.: Hyperlipidémie et tumeurs: L'activité lipasique postheparine du hamster porteur delymphome malin. C.R. Acad. Sci. Paris 280: 665668, 1975.
  • 3
    Bishop, M. C., and Ross, E. J.: Adrenocortical activity in disseminated malignant disease in relation to prognosis. Br. J. Cancer 24: 719725, 1970.
  • 4
    Blackburn, G. I., Maini, B. S., Bistrian, B. R., and McDermott, W. V., Jr.: The effect of cancer on nitrogen. electrolyte and mineral metabolism. Cancer Res. 37: 23482353, 1977.
  • 5
    Brenneman, D. E., Mathur, S. N., and Spertor, A. A.: Characterization of the hyperlipidemia in mice bearing the Ehrlich ascites tumor. Eur. J. Cancer 11: 225230, 1975.
  • 6
    Broghamer, W. L., Jr., McConnell, K. P., Grimaldi, M., and Blotcky, A. J.: Serum selenium and reticuloendothelial tumors. Cancer 41: 14621466, 1978.
  • 7
    Brown, R.: Carbohydrate metabolism in patients with endometrial carcinoma. J. Obstet. Gynecol. Br. Commonw. 81: 940946, 1974.
  • 8
    Burdick, J. F., Wells, S. A., and Herberman, R. B.: Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions. Surg. Gynecol. Obstet. 141: 779794, 1975.
  • 9
    Burk, D., Winzler, R. J.: Vitamins and cancer, In Vitamins and Hormones: Advances in Research and Applications, vol. 2. R. S.Harris, and K. V.Thimann, Eds. New York Academic Press, 1944; pp. 305352.
  • 10
    Carter, J. N., Eastman, C. J., Corcoran, J. M., and Lazarus, L.: Effect of severe chronic illness on thyroid function. Lancet 2: 971974, 1974.
  • 11
    Clark, C. M., and Goodlad, G. A. J.: Depletion of protein of phasic and tonic muscles in tumor-bearing rats. Eur. J. Cancer 7: 39, 1971.
  • 12
    Clark, C. M., and Goodlad, G. A. J.: Muscle protein biosyntheseis in the tumor-bearing rat: A defect in a postinitiation stage of translation. Biochem. Biophys. Acta 378: 230240, 1975.
  • 13
    Cohen, A., Heymsfield, S., Kuck, K., and Nixon, D.: Mechanisms of weight loss in hospitalized cancer patients. Clin. Res. 26: 36A, 1978 (Abstract).
  • 14
    Craig, A. R., Jr., and Waterhouse, C.: Body composition changes in patients with advanced cancer. Cancer 10: 11061109, 1957.
  • 15
    De Rosa, G., and Pitot, H. C.: Alterations in enzymes of amino acid catabolism in livers of rats bearing the Morris 7800 hepatoma. Cancer Res. 38: 950954, 1978.
  • 16
    Glicksman, A. S., and Rawson, R. W.: Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 9: 11271134, 1956.
  • 17
    Goodlad, G. A. J., and Clark, C. M.: Activity of gastrocnemius and soleus polyribosomes in rats hearing the Walker 256 carcinoma. Eur. J. Cancer 8: 647651, 1972.
  • 18
    Goodlad, G. A. J., Mitchell, J. H., McPhail, L., and Clark, C. M.: Serum insulin and somatomedin levels in the tumor-bearing rat. Eur. J. Cancer 11: 733737, 1975.
  • 19
    Gordon, K. S., Jr., and Cherkes, A.: Unesterified fatty acid in human blood plasma. J. Clin. Invest. 35: 206212, 1956.
  • 20
    Gordon, R. S., Jr., Cherkes, A., and Gates, H.: Unesterified fatty acid in human blood plasma: II. The transport function of unesterified fatty acid. J. Clin. Invest. 36: 810815, 1957.
  • 21
    Grande, F., Anderson, J. T., and Keys, A.: Changes of basal metabolic rate in men in semi-starvation and re-feeding. J. Appl. Physiol. 12: 230238, 1958.
  • 22
    Greenstein, J. P.: Biochemistry of Cancer, Second edition. New York, Academic Press, 1954; pp. 507543.
  • 23
    Greenstein, J. P.: Some biochemical characteristics of morphologically separable cancers. Cancer Res. 15: 641651, 1956.
  • 24
    Gutman, A., Thilo, E., and Biran, S.: Enzymes of gluconeogenesis in tumor-bearing rats. Israel J. Med. Sci. 5: 9981001, 1969.
  • 25
    Hall, T. C.: Ectopic synthesis and paraneoplastic syndromes. Cancer Res. 34: 20882091, 1974.
  • 26
    Herzfeld, A., and Greengard, O.: The dedifferentiated pattern of enzymes in livers of tumor-bearing rats. Cancer Res. 32: 18261832, 1972.
  • 27
    Herzfeld, A., and Greengard, O.: The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res. 37: 231238, 1977.
  • 28
    Holmes, D., Dickson, J. A., and Rennington, R. J.: Activity of some peptide hydrolases in muscle from tumor-bearing rats. Eur. J. Cancer 10: 683689, 1974.
  • 29
    Holroyade, C. P., Gabuzda, T. G., Putnam, R. C., Paul, P., and Reicherd, G. A.: Altered glucose metabolism in metastatic carcinoma. Cancer Res. 35: 37103714, 1975.
  • 30
    Hrgovcic, M., Tessmer, C. F., Thomas, F. B., Fuller, L. M., Gamble, J. F., and Schullenberger, C. C.: Significance of serum copper levels in adult patients with Hodgkin's disease. Cancer 31: 13371345, 1973.
  • 31
    Ilicin, G.: Serum copper and magnesium levels in leukemia and malignant lymphoma. Lancet 2: 10361037, 1971.
  • 32
    Islam, M. N.: Evidence for possible emergence of immuno-chemically distinct nucleotide peptides in malignant transformation. Experientia 34: 254255, 1978.
  • 33
    Kisner, D., Hamosh, M., Blecher, M., Haller, D., Jacobs, E., Peterson, B., and Schein, P.: Malignant cachexia: Insulin resistance and insulin receptors. Pror. Am. Assoc. Cancer Res. 19: 199, 1978 (Abstract).
  • 34
    Kralovic, R. C., Zepp, E. A., and Cenedella, R. J.: Studies of the mechanism of carcass fat depletion in experimental cancer. Eur. J. Cancer 13: 10711079, 1977.
  • 35
    Kreisherg, R. A., Owen, W. C., and Siegel, A. M.: On and endocrine disease. Med. Clin. N. Amer. 54: 14731494, 1970.
  • 36
    Lee, Y. T. N., Sparks, F. C., Eilber, F. R., and Morton, D. L.: Delayed cutaneous hypersensitivity and peripheral lymphocytic counts in patients with advanced cancer. Cancer 35: 748755, 1975.
  • 37
    Lehane, D. E., and Lane, M.: Immunocompetence in advanced cancer patients prior to chemotherapy. Oncology 30: 458466, 1974.
  • 38
    Liebelt, R. A., Liebelt, A. G., and Johnston, H. M.: Lipid mobilization and food intake in experimentally obese mice hearing transplanted tumors. Proc. Soc. Exp. Biol. Med. 138: 482490, 1971.
  • 39
    Lundholm, K., Bylund, A. C., and Scherstén, T.: Glucose tolerance in relation to skeletal muscle enzyme activities in cancer patients. Scand. J. Clin. Lab. Invest. 37: 267272, 1977.
  • 40
    Lundholm, K., and Scherstén, T.: Lysosomal enzyme activity in liver and muscle tissue and leurine incorporation rate into liver and muscle proteins in patients with malignant tumors. 1st Vienna Meeting Molecular Base of Malignancy. 1974: E.Deutsch, K.Moser, H.Rainer, and A.Stacher, Eds.; Stuttgart, Georg Thieme Pub. 1976; pp. 106110.
  • 41
    Marks, P. A., and Bishop, J.: Alterations in carbohydrate metabolism associated with neoplasia in men Proc. Am. Assoc. Cancer Res. 2: 131, 1956 (Abstract).
  • 42
    Marks, P. A., and Bishop, J.: Glucose metabolism in subjects with neoplastic disease: Response to insulin and glucose tolerance: Follow-up studies. Proc. Am. Assoc. Cancer Res. 2: 228229, 1957 (Abstract).
  • 43
    Mider, G. B., Tesluk, H., and Morton, J. J.: Effects of Walker carcinoma 256 on food intake, body weight and nitrogen metabolism of growing rats. Acta Un. Int. Cancer 6: 409420, 1948.
  • 44
    Monod, J., Changeux, J. P., and Jacob, F.: Allosteric proteins and cellular control systems. J. Mol. Biol. 6: 306329, 1963.
  • 45
    Mortazari, S. H., Bani-Hashemi, A., Mozafari, M., and Raffi, A.: Value of serum copper measurements in lymphoma and several other malignancies. Cancer 29: 11931198, 1972.
  • 46
    Muller, T. S., and Watkin, D. M.: Plasma unesterified fatty acid concentration in neoplastic disease. J. Lab. Clin. Med. 57: 95108, 1961.
  • 47
    Munro, H. N.: Tumor host competitions for nutrients in the cancer patient. J. Am. Diet. Assoc. 71: 380384, 1977.
  • 48
    Munson, D., Franco, D., Arbeter, A., Velez, H., and Vitale, J. J.: Serum levels of immunoglobulins, cell-mediated immunity and phagocytosis in protein-calorie malnutrition. Am. J. Clin. Nutr. 27: 625628, 1974.
  • 49
    Nowell, P. C.: The clonal evolution of tumor cell populations. Science 194: 2328, 1976.
  • 50
    Odell, W. D., Wolfsen, A. R., Yoshimoto, Y., Weitzman, R., Fisher, D., and Hirose, F.: Ectopic synthesis—A universal concomitant of neoplasia. Trans. Assoc. Am. Phys. 90: 204227, 1977.
  • 51
    O'Regan, S., Carson, S., Chesney, R. W., and Drummond, K. N.: Electrolyte and acid-base disturbances in the management of leukemia. Blood 49: 345353, 1977.
  • 52
    Owen, O. E., Felig, P., Morgan, A. P., Wahren, J., and Cahill, G. F.: Liver and kidney metabolism during prolonged starvation. J. Clin Invest. 48: 547583, 1969.
  • 53
    Pearson, O. H., Llerena, O., Samaan, N., and Gonzalez, D.: Serum growth hormone and insulin levels in patients with breast cancer. In Prognostic Factors in Breast Cancer, Tenovus Symposium, April, 1967: A. P. M.Forrest, and P. B.Kunkler, Eds. London, E. S. Livingstone, 1968; pp. 421430.
  • 54
    Pratt, A. W., and Putney, F. K.: Observations on the energy metabolism of rats receiving Walker tumor 256 transplants. J. Natl. Cancer Invest. 20: 173187, 1958.
  • 55
    Ratcliffe, J. G., Stark, B. H., Burt, K. W., Radcliffe, W. A., Spilg, W. G., Cuthhert, J., and Kennedy, R. S.: Thyroid function in lung cancer. Br. Med. J. 1: 210212, 1978.
  • 56
    Rossing, N.: Albumin metabolism in neoplastic diseases. Scand. J. Clin. Lab. Invest. 22: 211216, 1968.
  • 57
    Rudman, D., Chawla, R. K., Del Rio, A. E., and Hollins, B.: Isolation of a novel glycoprotein from the urine of a patient with chronic myelocytic leukemia. J. Clin. Invest. 53: 868874, 1974.
  • 58
    Rudman, D., Chawla, R. K., Hendrickson, I. J., Vogler, W. R., and Sophianopoulos, A. J.: Isolation of a novel glycoprotein (EDCI) from the urine of a patient with acute myelocytic leukemia. Cancer Res. 36: 18371846, 1976.
  • 59
    Rudman, D., Chawla, R. K., and Nixon, D. W.: The specific proteinuria of neoplastic disease. Clin. Res. 26: 563A, 1978.
  • 60
    Rudman, D., Chawla, R. K., Nixon, D. W., Roler, J. H., and Shah, V. R.: Isolation of novel glycoprotein HNCIG from the urine of a patient with acute monocytic leukemia. Cancer Res. 38: 602607, 1978.
  • 61
    Rudman, D., Del Rio, A., Akgun, S., and Frumin, E.: Novel proteins and peptides in the urine of patients with advanced neoplastic disease. Am. J. Med. 46: 174187, 1969.
  • 62
    Rudman, D., Vogler, W. R., Howard, C. H., and Gerron, G. G.: Observations on the plasma amino acids of patients with acute leukemia. Cancer Res. 31: 11591165, 1971.
  • 63
    Scherstén, T., and Lundholm, K.: Lysosomal enzyme activity in muscle tissue from patients with malignant tumor. Cancer 30: 12461251, 1972.
  • 64
    Scherstén, T., Wahlquist, L., and Jilderos, B.: Lysosomal enzyme activity in liver tissue, kidney tissue, and tumor tissue from patients with renal carcinoma. Cancer 27: 278283, 1971.
  • 65
    Schulze, B., Buchelt, L., Dittmann, H. W., und Mensch, K. W.: Biochemische Untersuchungen zum Problem der Tumorkachexie: II. Dekompensation der Glykogenolyse und Steigerung der Gluconeogenese beim Tumorwirt durch das Walker-Carcinom der Ratte. Z. Krebsforsch 85: 2938, 1976.
  • 66
    Schulze, B., Buchelt, L., Kurtze, G., und Lorenz, H. G.: Biochemische Untersuchungen zum Problem der Tumorkachexie: I. Tumorbedingte Veränderungen der Glykogenolyse und der Gluconeogenese beim Walker-Carcinom der Ratte. Z. Krebsforsch 85: 2128, 1976.
  • 67
    Schwartz, M. L.: Role of trace elements in cancer. Cancer Res. 35: 34813487, 1975.
  • 68
    Shapot, V. S.: Systemic effect of the tumor on the host: Biochemical and endocrine manifestations. Adv. Enzyme. Reg. 13: 6775, 1975.
  • 69
    Shapot, V. S., and Blinov, V. A.: Blood glucose levels and gluconeogenesis in animals bearing trans-plantable tumors. Cancer Res. 34: 18271832, 1974.
  • 70
    Sherman, E. D., Jr., Morton, J. J., and Mider, G. B.: Potential sources of tumor nitrogen. Cancer Res. 10: 374378, 1950.
  • 71
    Stein, T. P., Oram-Smith, J. C., Leskiw, M. J., Wallace, H. W., and Miller, E. E.: Tumor-caused changes in host protein synthesis under different dietary situations. Cancer Res. 36: 39263940, 1976.
  • 72
    Stonehill, E. H., and Bendick, A.: Retrogenetic expression: The reappearance of embryonal antigens in cancer cells. Nature 228: 370372, 1970.
  • 73
    Terepika, A. R., and Waterhouse, C.: Metabolic observations during the forced feeding of patients with cancer. Am. J. Med. 20: 225238, 1956.
  • 74
    Theologides, A.: Pathogenesis of cachexia in cancer: A review and a hypothesis. Cancer 29: 484488, 1972.
  • 75
    Theologides, A.: The anorexia cachexia syndrome: A new hypothesis. Ann. NY Acad. Sci. 230: 1422, 1974.
  • 76
    Theologides, A.: Vitamins and cancer. Minn. Med. 58: 875877, 1975.
  • 77
    Theologides, A.: Anorexia-producing intermediary metabolites. Am. J. Clin. Nutr. 29: 552558, 1976.
  • 78
    Theologides, A.: Weight loss in cancer patients. CA 27: 205208, 1977.
  • 79
    Theologides, A.: Cancer cachexia in nutrition and cancer. In Current Concepts in Nutrition, vol. 6, M.Winick, Ed. New York, John Wiley, 1977; pp. 7594.
  • 80
    Theologides, A., McHugh, R. B., Lindall, A. W., and Hall, S. M.: Post-hypophysectomy insulin response. Med. Ped. Oncol. 3: 9399, 1977.
  • 81
    Theologides, A., and Pegelow, C. H.: Liver weight changes during distant growth of transplanted tumor. Proc. Exp. Biol. Med. 134: 11041108, 1970.
  • 82
    Toporek, M.: Effects of whole blood or albumin fraction from tumor-bearing rats on liver protein synthesis. Cancer Res. 33: 25792583, 1973.
  • 83
    Waterhouse, C.: How tumors affect host metabolism. Ann. NY Acad. Sci. 230: 8693, 1974.
  • 84
    Waterhouse, C., and Nye, W. H. R.: Metabolic effects of infused triglyceride. Metabolism 10: 403414, 1961.
  • 85
    Watkin, D. M.: Increased fat utilization in the hypermetabolism of active neoplastic disease. Acta. Un. Int. Cancer 15: 907917, 1959.
  • 86
    Weller, M.: Cancer and endocrine dysfunction. Lancet 2: 330331, 1972.
  • 87
    Wood, R.: Hepatoma, host liver, and normal rat liver phospholipids as affected by diet. Lipids 10: 736745, 1975.
  • 88
    Wu, C., and Homburger, H. A.: Responsiveness of enzymes in liver to growth of Novikoff hepatoma. Br. J. Cancer 23: 204209, 1969.
  • 89
    Young, V. R.: Energy metabolism and requirements in the cancer patient. Cancer Res. 37: 23362347, 1977.